Diego Medvedofsky is a Cardiology physician. OpenAlex indexes 113 publications with 2,714 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5841 S Maryland Ave Ste Mc6080
University Of Chicago Medical Center, Cardiology
Chicago, IL 606371641
Telephone
773-834-5418Registry record last updated 10 Feb 2016.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Medtronic, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.9%Beta blocker18.2%Metoprolol Succinate53%Carvedilol29%Metoprolol Tartrate18%Part D≥29 patientsStatin18.1%Atorvastatin Calcium87%Rosuvastatin Calcium13%Part D≥43 patients+ 12 more classes in this area
Metabolism & gastrointestinal
6.9%SGLT2 inhibitor6.9%Jardiance85%Farxiga15%Part D<11 patientsBlood & clotting
6.2%Factor Xa inhibitor3.5%Eliquis100%Part D<11 patientsP2Y12 inhibitor1.6%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure
JACC. Cardiovascular imaging
2024 - Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial
Journal of the American Heart Association
2023 - Right Ventricular–Pulmonary Arterial Coupling in Patients With HF Secondary MR
JACC: Cardiovascular Interventions
2021 - Left Ventricular Global Longitudinal Strain as a Predictor of Outcomes in Patients with Heart Failure with Secondary Mitral Regurgitation: The COAPT Trial
Journal of the American Society of Echocardiography
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”